Bavarian Nordic

Valuation Analysis

About the Company

Bavarian Nordic en bref

Bavarian Nordic (BAVA.CO) is currently trading at 179,40 € with a market capitalization of 11,9 Md €. The trailing P/E ratio stands at 11.89x, with a forward P/E of 16.81x. The 52-week range spans from 165,80 € to 244,80 €; the current price is 26.7% below the yearly high. Year-over-year revenue growth stands at -21.4%. The net profit margin stands at 19.71%.

💰 Dividende

Bavarian Nordic currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Bavarian Nordic (BAVA.CO) au consensus : None. L'objectif de cours moyen est de 273,33 €, soit un potentiel de +52.36% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 260,00 € à 280,00 €.

Bavarian Nordic : la thèse d'investissement en détail

Bavarian Nordic (BAVA.CO) operates in the Healthcare — specifically Biotechnology — and is headquartered in Denmark. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue is contracting at -21.4% year-over-year — until that trend reverses, valuation is exposed to further downgrades.

Valorisation en contexte

The EV/EBITDA multiple of 8.28x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 52.36% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Bavarian Nordic?

Compare top-rated brokers — low fees, trusted providers, fully regulated.